News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
03 21 2023 New Panels Aimed at the Millions of Americans Still Suffering From COVID-19 Side Effects SECAUCUS, N.J., March 21, 2023 /PRNewswire/ -- The consumer-initiated testing business from the leader in...
-
03 20 2023 Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of select assets of Northern...
-
03 16 2023 Updates 2023-26 compound annual growth rate (CAGR): Revenues expected to grow at mid single-digit rate; adjusted diluted earnings per share (EPS)* expected to grow at high single-digit rate...
-
03 03 2023 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors elected James E. Davis, the company's Chief Executive...
02 16 2023 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Tower Health, a regional integrated healthcare system in Pennsylvania, are teaming up to enhance...
-
02 14 2023 Goal to serve NewYork-Presbyterian's providers and patients in the greater New York region and beyond SECAUCUS, N.J. and NEW YORK, Feb. 14, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the...
-
02 13 2023 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts in New York City on...
-
02 02 2023 Fourth quarter revenues of $2.33 billion, down 15.0% from 2021 Fourth quarter reported diluted earnings per share ("EPS") of $0.87, down 72.1% from 2021; and adjusted diluted EPS of $1.98, down...
-
02 02 2023 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the Company's Board of Directors has authorized a 7.6% increase in its...
-
02 01 2023 Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2023...